Achievements of Guilin Hua Nuo Wei Gene Pharmaceutical Co., Ltd.

The Basic Research Institute of China Academy of Medical Sciences has obtained the invention patent certificate of "Epidermal Growth Factor Engineering Bacteria and the Method for Preparing Growth Factors by Using the Bacteria" issued by the State Patent Office, with the patent number ZL 97 1 152845, which has independent intellectual property rights, and our company has the exclusive license right for this patent.

After 8 years' efforts, our company obtained the national first-class certificate of recombinant human epidermal growth factor eye drops (Yi Bei) in May 2000 and the national first-class certificate of recombinant human epidermal growth factor gel (skin-benefiting) in 2002. It is the first successful expression of Guilin Hua Nuo Wei Gene Pharmaceutical Co., Ltd. with yeast in China, and it is also the only biopharmaceutical enterprise with two national first-class drugs in Guangxi.

The gene drug production workshop of Guilin Hua Nuo Wei Gene Pharmaceutical Co., Ltd. was designed by Shanghai Pharmaceutical Industry Design Institute, with an area of 23,000 square meters and a building area of 8 148 square meters. With an investment of 654.38 billion yuan, the project started in May 654.38+0999 and was completed in May 54.38+0, 2006. At present, the production lines of recombinant human epidermal growth factor (rhEGF) eye drops and recombinant human epidermal growth factor (rhEGF) gel have passed the national GMP certification, and the products are sold in more than 654.38+0000 3A hospitals nationwide.